CSF1R and neoplasm: Furthermore, inhibiting the colony-stimulating factor-1 receptor (CSF1R) in TAMs might significantly reduce tumor-initiating cells (TICs), hence relieving immunosuppression and overcoming TIC-mediated chemotherapeutic resistance [33].